Related Experiment Video
Updated: Feb 20, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
82.0K
A Nomogram Predictive Model for Drug-Resistant Tuberculosis Detection by GeneXpert MTB/RIF Assay in Paediatric
Lingchao Wang1, Weiwei Ma1, Na Wei1
1Department of Pediatric, The First Affiliated Hospital of Henan Medical University (formerly The First Affiliated Hospital of Xinxiang Medical University), Weihui, 453100, People's Republic of China.
Infection and Drug Resistance
|February 19, 2026
Summary
A new nomogram effectively predicts drug-resistant tuberculosis (DR-TB) risk in pediatric patients, identifying retreatment and smoking as key factors. The GeneXpert MTB/RIF assay shows promise for early DR-TB screening in children.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Diagnostics
- Radiology and Imaging
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in pediatric populations.
- Drug-resistant TB (DR-TB) presents a complex treatment scenario, necessitating accurate risk prediction and diagnostic tools.
- Identifying risk factors and developing predictive models for DR-TB in children is crucial for timely intervention.
Purpose of the Study:
- To develop and validate a clinical-imaging integrated nomogram for predicting DR-TB risk in pediatric patients (≤18 years).
- To evaluate the diagnostic performance of the GeneXpert MTB/RIF assay for DR-TB detection in this age group.
- To identify independent risk factors associated with DR-TB in hospitalized children and adolescents.
Main Methods:
- Retrospective study of 223 TB patients aged ≤18 years.
- Analysis of drug resistance profiles and comparison of clinical/imaging features between DR-TB and drug-susceptible TB (DS-TB) groups.
- Multivariate logistic regression to identify DR-TB risk factors and development of a nomogram predictive model.
Main Results:
- DR-TB was present in 26.5% of patients, with 13.5% having multidrug-resistant TB.
- Independent DR-TB risk factors identified: retreatment (OR=5.303), smoking history (OR=4.129), right middle lobe involvement (OR=3.004), and cavity formation (OR=2.950).
- The nomogram model demonstrated effective predictive performance (AUC=0.776). GeneXpert MTB/RIF showed 87.5% sensitivity and 90.48% specificity for rifampicin resistance.
Conclusions:
- A clinical-imaging nomogram model shows good predictive value for DR-TB risk in pediatric patients.
- Retreatment, smoking history, right middle lobe involvement, and cavity formation are significant predictors of DR-TB.
- GeneXpert MTB/RIF assay is a potential early screening tool for DR-TB in children, warranting further validation.
Related Concept Videos
Pulmonary Tuberculosis V
656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557

